Visitor Monitoring Drug History: NAPROSYN
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: NAPROSYN
FDA Application No: (NDA) 018965
Active Ingredient(s): NAPROXEN
Company: ROCHE PALO
 
Label History
 
View the label approved on September 26, 2007 for NAPROSYN, (NDA) 018965


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
9/20/2007 016Labeling Revision Letter
Label 
4/19/2007 015Labeling Revision Letter 
1/24/2006 014Labeling Revision Letter
Label 
3/10/2006 013Labeling Revision Letter
Label 
2/22/2002 012Manufacturing Change or Addition  
1/5/2001 011Manufacturing Change or Addition  
11/10/2004 010Labeling Revision Letter
Label 
11/10/2004 009Labeling Revision Letter
Label 
11/14/1996 008Manufacturing Change or Addition  
4/14/2003 007Labeling Revision Letter 
9/12/1994 006Control Supplement  
1/27/1993 004Manufacturing Change or Addition  
3/23/1987 000Approval  
 
Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test